ATE134649T1 - Arzneimittel und verfahren zur behandlung von erworbenem immundefizienzsyndrom (aids) und aids- verwandtem komplex unter verwendung von karbohydratspezifischen antikörpern - Google Patents

Arzneimittel und verfahren zur behandlung von erworbenem immundefizienzsyndrom (aids) und aids- verwandtem komplex unter verwendung von karbohydratspezifischen antikörpern

Info

Publication number
ATE134649T1
ATE134649T1 AT91900749T AT91900749T ATE134649T1 AT E134649 T1 ATE134649 T1 AT E134649T1 AT 91900749 T AT91900749 T AT 91900749T AT 91900749 T AT91900749 T AT 91900749T AT E134649 T1 ATE134649 T1 AT E134649T1
Authority
AT
Austria
Prior art keywords
aids
carbohydrate
drugs
methods
specific antibodies
Prior art date
Application number
AT91900749T
Other languages
English (en)
Inventor
John-Erik Stig Hansen
Henrik Clausen
Original Assignee
Bay Dev Corp Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bay Dev Corp Sa filed Critical Bay Dev Corp Sa
Application granted granted Critical
Publication of ATE134649T1 publication Critical patent/ATE134649T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/34Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood group antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT91900749T 1990-01-26 1990-12-13 Arzneimittel und verfahren zur behandlung von erworbenem immundefizienzsyndrom (aids) und aids- verwandtem komplex unter verwendung von karbohydratspezifischen antikörpern ATE134649T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US47066690A 1990-01-26 1990-01-26

Publications (1)

Publication Number Publication Date
ATE134649T1 true ATE134649T1 (de) 1996-03-15

Family

ID=23868522

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91900749T ATE134649T1 (de) 1990-01-26 1990-12-13 Arzneimittel und verfahren zur behandlung von erworbenem immundefizienzsyndrom (aids) und aids- verwandtem komplex unter verwendung von karbohydratspezifischen antikörpern

Country Status (10)

Country Link
EP (2) EP0511967B1 (de)
JP (2) JPH05506565A (de)
AT (1) ATE134649T1 (de)
AU (1) AU653141B2 (de)
CA (2) CA2074512A1 (de)
DE (1) DE69025629T2 (de)
ES (1) ES2082962T3 (de)
FI (1) FI923348A (de)
NO (1) NO922941L (de)
WO (2) WO1991011528A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2044741A1 (en) * 1990-06-18 1991-12-19 Jade Chin Hiv gp120 monoclonal antibodies
JP2002530071A (ja) 1998-11-13 2002-09-17 クラウセン、ヘンリク UDPガラクトース:β−N−アセチル−グルコサミンβ1,3ガラクトシルトランスフェラーゼ、β3Gal−T5
US6800468B1 (en) 1998-11-13 2004-10-05 Henrik Clausen UDP-galactose: β-N-acetyl-glucosamine β1,3galactosyltransferases, β3Gal-T5
WO2005078443A1 (en) * 2004-02-13 2005-08-25 Inverness Medical Switzerland Gmbh Determination of infection by the immune response to a carbohydrate moiety

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH083487B2 (ja) * 1987-07-31 1996-01-17 株式会社日本抗体研究所 異常応答リンパ球の検出方法並びにこれに用いる検出用試薬及びキット
WO1989008711A1 (en) * 1988-03-11 1989-09-21 The Biomembrane Institute Monoclonal antibodies and vaccine development directed to human cancer-associated antigens by immunization with animal and human mucin and with synthetic carbohydrate-carrier conjugates

Also Published As

Publication number Publication date
DE69025629T2 (de) 1996-07-04
WO1991011528A1 (en) 1991-08-08
EP0512023A4 (en) 1993-06-30
FI923348A0 (fi) 1992-07-23
DE69025629D1 (de) 1996-04-04
WO1991011199A1 (en) 1991-08-08
EP0511967B1 (de) 1996-02-28
JPH05506565A (ja) 1993-09-30
NO922941L (no) 1992-09-17
EP0511967A1 (de) 1992-11-11
AU653141B2 (en) 1994-09-22
CA2074512A1 (en) 1991-07-27
JPH05506843A (ja) 1993-10-07
NO922941D0 (no) 1992-07-24
FI923348A (fi) 1992-07-23
CA2073459A1 (en) 1991-07-27
ES2082962T3 (es) 1996-04-01
EP0512023A1 (de) 1992-11-11
AU6961491A (en) 1991-08-21

Similar Documents

Publication Publication Date Title
DE69233012D1 (de) Mit staphylococcus epidermidis assoziierte oberflächenantigene des typs i
DE69230545D1 (de) Antikörperderivate
NO169844C (no) Htlv-iii (env)-peptider
ATE301471T1 (de) Verwendung von antikörpen gegen cd45ro leukozytenantigen zur immunmodulation
FI931393A0 (fi) Peptider foer anvaendning vid vaccinering och induktion av neutraliserande motkroppar mot humant immunbristvirus
DK388384D0 (da) Monoklone antistoffer med specifitet for membran-associerede antigene, deres fremstilling og anvendelse
NO302176B1 (no) Fremgangsmåte for fremstilling av et monoklonalt antistoff og et antigen
CA2004478A1 (en) Monoclonal antibodies to feline-t-lymphotropic lentivirus
ATE166230T1 (de) Verwendung von anti-icam antikörpern zur herstellung eines präparats für die behandlung von endotoxinschock
DE69029134D1 (de) Monoklonale antikörper zur induzierung von toleranz
DE69127487D1 (de) Verfahren zum Nachweis der Alzheimer-Krankheit
DE3854553D1 (de) Verfahren zum schnellen und empfindlichen Nachweis von IgM-Antikörpern gegen retrovirale Antigene.
SE9000333D0 (sv) Monoklonal antikropp
ATE134649T1 (de) Arzneimittel und verfahren zur behandlung von erworbenem immundefizienzsyndrom (aids) und aids- verwandtem komplex unter verwendung von karbohydratspezifischen antikörpern
DK442888A (da) Slaegtspecifikt listeria-antigen identificeret ved hjaelp af monoklone antistoffer
DK140992D0 (da) Fremgangsmaade til frembringelse af antistoffer mod haptener og andre b-celle-antigener, antistoffer opnaaet ved fremgangsmaaden og anvendelse af disse antistoffer til fremstilling af vacciner, isaer til veterinaermedicinsk brug
ES2013665A6 (es) Procedimiento para preparar un anticuerpo monoclonal humano y metodo de uso.
DK0513565T3 (da) Monoklonale antistoffer mod plasmin-antiplasmin-komplekset, fremgangsmåde til deres fremstilling og deres anvendelse
ATE110786T1 (de) Monoklonaler antikörper gegen exotoxin a von pseudomonas aeruginosa.
DE68918440D1 (de) Verfahren zur transformation von menschlichen b-lymphocyten.
AU1508088A (en) Monoclonal antibodies to specific antigenic regions of the human immunodeficiency virus and methods for use
IT1254570B (it) Antigeni legati alla superfice esterna di eritrociti e procedimento per la loro preparazione.
IT8821547A0 (it) Metodo immunologico per la determinazione di anticorpi anti antigeni di microorganismi, mediante anticorpi antiidiotipo e mezzi adatti allo scopo.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties